NCT05937828View on ClinicalTrials.gov

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

RecruitingOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

September 1, 2010

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome
Interventions
OTHER

data collection

description of the long-term health of adult patients, identification of the heterogenous genetic underlying pathophysiologic contexts, study of the benefit-risk balance of treatments, including the growing development of targeted therapies.

Trial Locations (9)

Unknown

RECRUITING

CHU Amiens Picardie Service d' Onco-Immuno-Hématologie Pédiatrique, Amiens

RECRUITING

CHU d'Angers Unité d'Hémato-Oncologie Pédiatrique, Angers

RECRUITING

BESANCON CHU de Besançon Hôpital Jean MINJOZ Unité d'Hémato-Oncologie Pédiatrique, Pédiatrie 1, Besançon

RECRUITING

CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique, Bordeaux

RECRUITING

CHU BREST Hôpital Morvan Unité d'Onco-Hématologie, Brest

RECRUITING

CHU de Caen Unité d'Onco-Hématologie, Caen

RECRUITING

CHU de Clermont Ferrand, Clermont-Ferrand

RECRUITING

APHP Hôpital Bicêtre Service de Pédiatrie générale, Paris

RECRUITING

CH de Cornouaille Service de Pédiatrie, Quimper

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT05937828 - OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia | Biotech Hunter | Biotech Hunter